Ondine Biomedical Inc. (AIM:OBI)
London · Delayed Price · Currency is GBP · Price in GBX 10.00
-0.30 (-2.91%)
Sep 25, 2026, 11:24 AM GMT
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 53.51 million as of September 24, 2026. Its market cap has decreased by -19.69% in one year.
Market Cap
53.51M
Enterprise Value
48.01M
Revenue
1.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.00
ChartMarket Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 53.51M, a decrease of -52.58%. That is a compound annual growth rate of -14.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 53.51M | 37.67% |
| Dec 31, 2025 | 38.87M | 9.33% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
| Dec 6, 2021 | 112.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 117.59M |
| 4basebio | 87.40M |
| Bioventix | 80.99M |
| Faron Pharmaceuticals Oy | 73.32M |
| Poolbeg Pharma | 60.31M |
| Sareum Holdings | 43.65M |
| Arecor Therapeutics | 33.41M |
| Hemogenyx Pharmaceuticals | 31.28M |